BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 34752759)

  • 1. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
    Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
    J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Adherence to Annual Lung Cancer Screening and Recommended Follow-Up Care: A Multicenter Cohort Study.
    Kim RY; Rendle KA; Mitra N; Saia CA; Neslund-Dudas C; Greenlee RT; Burnett-Hartman AN; Honda SA; Simoff MJ; Schapira MM; Croswell JM; Meza R; Ritzwoller DP; Vachani A
    Ann Am Thorac Soc; 2022 Sep; 19(9):1561-1569. PubMed ID: 35167781
    [No Abstract]   [Full Text] [Related]  

  • 3. Adherence to Annual Lung Cancer Screening in a Centralized Academic Program.
    Lee G; Hill LP; Schroeder MC; Kraus SJ; El-Abiad KMB; Hoffman RM
    Clin Lung Cancer; 2024 Jan; 25(1):e18-e25. PubMed ID: 37925362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Downstream Procedures on Lung Cancer Screening Adherence.
    Tailor TD; Bell S; Carlos RC
    J Am Coll Radiol; 2023 Oct; 20(10):969-978. PubMed ID: 37586471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program.
    Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF
    Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting lung cancer screening of high-risk patients by primary care providers.
    Colamonici M; Khouzam N; Dell C; Auge-Bronersky K; Pacheco E; Rubinstein I; Recht B
    Cancer; 2023 Nov; 129(22):3574-3581. PubMed ID: 37449669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Delay in Lung Cancer Diagnosis and Surgery in a Lung Cancer Screening Program.
    El Alam R; Hammer MM; Byrne SC
    J Thorac Imaging; 2024 Mar; ():. PubMed ID: 38454761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Procedures Associated With Lung Cancer Screening in Clinical Practice.
    Manyak A; Seaburg L; Bohreer K; Kirtland SH; Hubka M; Gerbino AJ
    Chest; 2023 Aug; 164(2):544-555. PubMed ID: 36781101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A predictive model for lung cancer screening nonadherence in a community setting health-care network.
    Bastani M; Chiuzan C; Silvestri G; Raoof S; Chusid J; Diefenbach M; Cohen SL
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 37027213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot intervention to increase uptake of lung cancer screening through the emergency department.
    Pettit NR; Horner D; Freeman S; Rieger K
    Am J Emerg Med; 2024 May; 79():157-160. PubMed ID: 38432156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Annual Lung Cancer Screening After Baseline Screening Among Screen-Negative Individuals: No-Cost Coverage Is Not Enough.
    Tailor TD; Bell S; Doo FX; Carlos RC
    J Am Coll Radiol; 2023 Jan; 20(1):29-36. PubMed ID: 36436778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening.
    Núñez ER; Zhang S; Glickman ME; Qian SX; Boudreau JH; Lindenauer PK; Slatore CG; Miller DR; Caverly TJ; Wiener RS
    Am J Respir Crit Care Med; 2024 Jan; 209(2):197-205. PubMed ID: 37819144
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding Factors Associated with Uptake of Lung Cancer Screening among Individuals at High Risk.
    Gudina AT; Kamen C; Cheruvu VK; Cupertino P; Rivera MP
    J Health Care Poor Underserved; 2023; 34(2):719-730. PubMed ID: 37464528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographics and socioeconomic determinants of health predict continued participation in a CT lung cancer screening program.
    Wang Z; Kim Y; Mortani Barbosa EJ
    Curr Probl Diagn Radiol; 2024 Apr; ():. PubMed ID: 38658287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network.
    Udelsman BV; Detterbeck F; Tanoue L; Mase V; Boffa D; Blasberg J; Dhanasopon A; Ely S; Mazzarelli LJ; Bader A; Woodard G
    J Comput Assist Tomogr; 2024 Mar-Apr 01; 48(2):222-225. PubMed ID: 37832536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
    Hammer MM; Byrne SC
    AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
    Byrne SC; Hammer MM
    AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of Diagnostic CT and Patient Retention in a Lung Cancer Screening Program.
    Byrne SC; Hammer MM
    J Am Coll Radiol; 2022 Jan; 19(1 Pt A):47-52. PubMed ID: 34752759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.